- 1. 1 INT MAM-COR ART BYPASS
- [Direct myocardial revascularization in which the internal mammary artery is anastomosed to the right coronary artery, circumflex artery, or anterior descending coronary artery. The internal mammary artery is the most frequent choice, especially for a single graft, for coronary artery bypass surgery. ( MSH )] (UMLS (ICD9CM) C0021781) =Therapeutic or Preventive Procedure ;
| - 51. INADEQUATE HOUSING
- [ ] (UMLS (ICD9CM) C0260793) =Finding
|
- 2. 1,3-Indandione, 2-(p-methoxyphenyl)-
- [A synthetic indanedione anticoagulant. Anisindione interferes with the vitamin K-dependent hepatic synthesis of active clotting factors by inhibiting the reduction of vitamin K. This leads to an inhibition of gamma-carboxylation of glutamic acid residues to gamma-carboxyglutamic acid in clotting factors II, VII, IX and X. The consequential effects of this inhibition include a reduced activity of these clotting factors and prolonged blood clotting time. ( NCI )] (UMLS (NCI) C0051919) =Organic Chemical; Pharmacologic Substance ;
=[BL100] ANTICOAGULANTS;
PHENINDIONE =ANISINDIONE 50 MG | - 52. INADV RADIAT EXP-MEDICAL
- [ ] (UMLS (ICD9CM) C0261547) =Injury or Poisoning
|
- 3. 111 In-B3
- [A radioimmunoconjugate of monoclonal antibody (MoAb) B3 labeled with Indium 111 (In-111). MoAb B3 is a murine MoAb that recognizes a Lewis Y carbohydrate antigen present on the surface of many carcinomas. This radioimmunoconjugate emits gamma radiation and X-Ray photons that can be captured by gamma camera allowing imaging of Lewis Y expressing tissues. ( NCI )] (UMLS (NCI) C0935762) In 111 Monoclonal Antibody B3;
Indium In 111 Monoclonal Antibody B3 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 53. Inaja Band of Diegueno Mission Indians of the Inaj
- (UMLS (HL7) C1554327) =Population Group =NativeEntityContiguous;
|
- 4. 111 Indium
- [A radioisotope with a physical half-life of 2.83 days, used to label agents for diagnosis, disease progression and treatment. (NCI) ( NCI )] (UMLS (NCI) C0303403) =Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope ;
=[DX201] IMAGING AGENTS (IN VIVO) RADIOPHARMACEUTICALS;
Unclassified Ingredients =INDIUM In 111 CAPROMAB PENDETIDE | - 54. INAPERISONE
- (UMLS (NCI) C0062996) =Organic Chemical; Pharmacologic Substance ;
|
- 5. 2 INT MAM-COR ART BYPASS
- [ ] (UMLS (ICD9CM) C0190242) =Therapeutic or Preventive Procedure
| - 55. Inapparent Infection
- [Infection associated with no detectable symptoms but caused by microorganisms capable of producing easily recognizable diseases, such a poliomyelitis or mumps. ( NCI )] (UMLS (NCI) C0275522) =Disease or Syndrome
|
- 6. 5'-Inosinic Acid, Homopolymer Complex with 5'-Cytidylic Acid Homopolymer
- [interferon inducer consisting of a synthetic, mismatched double-stranded RNA; the polymer is made of one strand each of polyinosinic acid and polycytidylic acid. ( CSP )] (UMLS (NCI) C0032414) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =interferon inducer;
polynucleotide | - 56. Inappropriate
- (UMLS (HL7) C1548788) =Qualitative Concept =Specimen Appropriateness;
|
- 7. IN
- [western Asian republic comprising the major part of the Indian subcontinent; capital New Delhi. ( CSP )] (UMLS (NCI) C0021201) =Geographic Area ;
=Asia;
◊ [A state in the north central United States. Its capital is Indianapolis. ( NCI )] (UMLS (NCI) C0021206) Geographic Area ; | - 57. Inappropriate diet and eating habits
- [ ] (UMLS (ICD9CM) C0348088) =Finding
|
- 8. In
- [metallic element, atomic number 49, atomic weight 114.82, symbol In. ( CSP )] (UMLS (NCI) C0021223) =Element, Ion, or Isotope ;
=heavy metal;
| - 58. Inappropriate due to _
- (UMLS (HL7) C1548786) =Qualitative Concept =Specimen Appropriateness;
|
- 9. In
- [Being or existing in a specified place or at the specified time. ( NCI )] (UMLS (NCI) C0150312) =Quantitative Concept
| - 59. Inappropriate [too hot or too cold] temperature in local application and packing
- [ ] (UMLS (ICD9CM) C0418626) =Injury or Poisoning
|
- 10. In 111 Folic Acid
- [A radioimmunoconjugate of folic acid labeled with indium 111 (In-111) with immunotherapeutic property. In 111 folic acid emits gamma radiation and X-Ray photons that can be captured by gamma camera allowing imaging of tumor cells that express folate receptors. ( NCI )] (UMLS (NCI) C0796481) Indium In 111 Folic Acid =Organic Chemical; Pharmacologic Substance ;
| - 60. Inapsine
- (UMLS (NCI) C0699335) =Organic Chemical; Pharmacologic Substance ;
|
- 11. In 111 Ibritumomab Tiuxetan
- [A radiolabeled antibody that is being studied in cancer treatment. ( NCI )] (UMLS (NCI) C0796508) Indium In 111 Ibritumomab Tiuxetan =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 61. inborn aminoacidopathy
- [ ] (UMLS (CSP) C0598674) =Disease or Syndrome ;
|
- 12. In 111 LL2 IgG
- [A radioimmunoconjugate of the humanized IgG1 monoclonal antibody (MoAb) LL2 (epratuzumab) labeled with indium 111 (In-111). MoAb LL2 recognizes CD22, a B-lymphocyte-restricted antigen expressed as a cytoplasmic protein in progenitor B cells, and as a cell surface protein in mature B cells. In-111 MoAb LL2 emits gamma radiation and X-Ray photons that can be captured by gamma camera allowing imaging of tumor cells that express CD22 antigen. ( NCI )] (UMLS (NCI) C0879621) In 111 Monoclonal Antibody LL2;
Indium In 111 LL2 IgG;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 62. inborn aminoaciduria
- [ ] (UMLS (CSP) C0598675) =Disease or Syndrome ;
|
- 13. In 111 MoAB Hu3S193
- [A radioimmunoconjugate of humanized monoclonal antibody (MoAb) 3S193 labelled with Indium 111 (In-111). MoAb Hu3S193 recognizes a Lewis Y carbohydrate antigen present on the surface of many carcinomas. This radioimmunoconjugate emits gamma radiation and X-ray photons, thereby allows detection of tumor localization and distribution of MoAb HuS193 in diagnostic imaging procedures. ( NCI )] (UMLS (NCI) C0879605) In 111 Monoclonal Antibody Hu3S193;
Indium In 111 Monoclonal Antibody Hu3S193;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 63. inborn biological transport disorder
- [condition in which there is a deviation or interruption in the movement of materials (including biochemical substances and drugs) through a biological system at the cellular level; the defects in transport can occur within intracellular and extracellular compartments. ( CSP )] (UMLS (CSP) C0596765) =Disease or Syndrome =Congenital Metabolic Disorder;
=Bartter's Disease;
cystic fibrosis;
De Toni-Debre-Fanconi Syndrome;
inborn renal tubular transport disorder;
hereditary carnitine deficiency myopathy;
vitamin B12 transport defect;
familial hypophosphatemia in rickets;
congenital sucrose isomaltose malabsorption |
- 14. In 111 MOAB Lym-1
- [A radioimmunoconjugate of a murine monoclonal antibody, MoAb Lym-1, labeled with indium 111 (In-111). MoAb Lym-1 recognizes an epitope of the histocompatibility antigen HLA-DR, which is over-expressed on most B-cell lymphomas. In-111 MoAb Lym-1 emits gamma radiation and X-Ray photons that can be captured by gamma camera allowing imaging of tumor cells that express HLA-DR antigen. ( NCI )] (UMLS (NCI) C0796676) In 111 Monoclonal Antibody Lym-1;
Indium In 111 MoAb Lym-1;
Indium In 111 Monoclonal Antibody Lym-1 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 64. inborn epithelial transport disorder
- [ ] (UMLS (CSP) C0598676) =Disease or Syndrome ;
|
- 15. In 111 MOAB m170
- [A radioimmunoconjugate of the monoclonal antibody (MoAb) M170 labelled with Indium 111 (In-111). MoAb M170 recognizes an epitope of MUC1 mucins, which are up-regulated in human many adenocarcinoma. In-111 MoAb M170 emits gamma radiation and X-ray photons, thereby allows detection of tumor localization and distribution of MoAb M170 in diagnostic imaging procedures. ( NCI )] (UMLS (NCI) C0796670) In 111 Monoclonal Antibody M170;
Indium In 111 MoAb M170;
Indium In 111 Monoclonal Antibody m170;
MOAB M170, indium In 111;
monoclonal antibody M170, indium In 111 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 65. inborn immunodeficiency
- [genetically or developmently determined deficiency of immune response or disorder that is characterized by deficient immune response. ( CSP )] (UMLS (CSP) C0392207) =Disease or Syndrome ;
=hypoimmunity;
Congenital Metabolic Disorder =DiGeorge Anomaly;
Phagocyte Bactericidal Dysfunction;
Aldrich syndrome;
combined T and B cell inborn immunodeficiency;
complement deficiency |
- 16. In 111 MOAB MN-14
- [A radioimmunoconjugate of a murine monoclonal antibody, MoAb MN-14, labeled with indium 111 (In-111). MoAb Lym-1 recognizes recognizes an epitope of carcinoembryonic antigen (CEA), which is over-expressed in many tumor cell types. In-111 MoAb MN-14 emits gamma radiation and X-Ray photons that can be captured by gamma camera allowing imaging of tumor cells that express CEA. ( NCI )] (UMLS (NCI) C0879254) In 111 Monoclonal Antibody MN-14;
Indium In 111 MoAb MN-14;
Indium In 111 Monoclonal Antibody MN-14;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 66. inborn lipid disorder
- [ ] (UMLS (CSP) C0920558) =Disease or Syndrome
|
- 17. In 111 Monoclonal Antibody BrE-3
- [A humanized monoclonal antibody conjugated to the imaging radioisotope (indium-111). This radioimmunoconjugate binds to the breast epithelial mucin antigen, which is found primarily on breast cancer cells, permitting radioactive immunodetection of mucin-positive tumor cells and an estimate of radiation dosimetry prior to administration of cytotoxic radiotherapy. (NCI04) ( NCI )] (UMLS (NCI) C0935732) Indium In 111 Monoclonal Antibody BrE-3 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 67. inborn lipid storage disorder
- [disturbance of lipid metabolism with abnormal deposit of lipids in the cells. ( CSP )] (UMLS (CSP) C0023794) =Disease or Syndrome =Lipid Metabolism, Inborn Errors;
inborn lipid/lipoprotein disorder =cholesterol ester storage disease;
I cell disease;
hereditary ceroid lipofuscinosis;
heredopathia atactica polyneuritiformis;
Sphingolipidoses;
Wolman Disease;
cerebrotendinous xanthomatosis;
cholesterol ester storage disease;
Lipoidproteinosis;
hereditary ceroid lipofuscinosis;
heredopathia atactica polyneuritiformis;
Sjogren Larsson syndrome;
Sphingolipidoses;
Wolman Disease |
- 18. In 111 Pentetreotide
- [An anticancer drug belonging to a family of drugs called radiopharmaceuticals. ( NCI )] (UMLS (NCI) C0379955) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
| - 68. inborn lipid/lipoprotein disorder
- [genetically determined biochemical disorders in lipid/lipoprotein transport, apolipoprotein synthesis, HDL synthesis, enzyme deficiency or gene mutation that involves the lipid/lipoprotein metabolism pathway. ( CSP )] (UMLS (CSP) C0178714) =Disease or Syndrome =Congenital Metabolic Disorder;
Alteracoes do metabolismo lipidico =inborn lipid storage disorder;
RSH Syndrome;
familial hypolipoproteinemia;
familial hyperlipoproteinemia |
- 19. In 111 Satumomab Pendetide
- [An radioimmunoconjugate of the murine monoclonal antibody, Satumomab (MoAb B72.3), conjugated to the linker-chelator, glycyl-tyrosyl-(N,-diethylenetriaminepentaacetic acid)-lysine hydrochloride (GYK-DTPA-HCl; pendetide) labeled with indium 111 (In-111). Satumomab recognizes TAG-72, an antigen expressed by the majority of adenocarcinomas. In-111 Satumomab pendetide emits gamma radiation and X-Ray photons that can be captured by gamma camera allowing imaging of TAG-72 expressing tissues. ( NCI )] (UMLS (NCI) C0209389) =Amino Acid, Peptide, or Protein; Indicator, Reagent, or Diagnostic Aid
| - 69. inborn lipoprotein disorder
- [ ] (UMLS (CSP) C0920559) =Disease or Syndrome
|
- 20. In an outside meeting
- [The Physician is in a meeting. For example, he/she may request administrative time to talk to family after appointment ( HL7V3.0 )] (UMLS (HL7) C1555026) =Idea or Concept =SchedulingActReason;
| - 70. inborn lysosomal enzyme disorder
- [inborn errors of metabolism characterized by defects in specific lysosomal hydrolases and resulting in intracellular accumulation of unmetabolized substrates. ( CSP )] (UMLS (CSP) C0085078) =Disease or Syndrome ;
=Congenital Metabolic Disorder;
=cholesterol ester storage disease;
alpha fucosidase deficiency;
Gangliosidoses;
I cell disease;
beta galactocerebrosidase deficiency;
arylsulfatase A deficiency;
Mucopolysaccharidoses;
Sphingolipidoses;
Wolman Disease;
mannosidase deficiency;
cholesterol ester storage disease;
Mucopolysaccharidoses;
Wolman Disease;
Lysosomal Storage Diseases, Nervous System;
mannosidase deficiency |
- 21. In Person
- (UMLS (HL7) C1547564) =Idea or Concept =Authorization Mode;
| - 71. inborn metabolism disorder clinical registry
- [ ] (UMLS (CSP) C0599086) =Intellectual Product ;
|
- 22. In Position
- (UMLS (HL7) C1550045) =Idea or Concept ;
=Container status;
◊ [Used by one system to inform another that the container is in position for specimen transfer (e.g., container removal from track, pipetting, etc.). ( HL7V3.0 )] (UMLS (HL7) C1551389) Intellectual Product ActContainerRegistrationCode; | - 72. inborn metabolism disorder diagnosis
- [determination of the presence of errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero based on symptoms, medical history, risk factors, and clinical tests. ( CSP )] (UMLS (CSP) C0596766) =Diagnostic Procedure =genetic disorder diagnosis;
metabolism disorder diagnosis |
- 23. In Process
- (UMLS (HL7) C1550044) =Idea or Concept ;
=Container status;
◊ [Used by one system to inform another that the specific container is being processed by the equipment. It is useful as a response to a query about Container Status, when the specific step of the process is not relevant. ( HL7V3.0 )] (UMLS (HL7) C1551390) Functional Concept ActContainerRegistrationCode; | - 73. inborn metal metabolism disorder
- [genetically determined biochemical disorders in metal absorption, metal excretion, metal transport, or incorporation of metal to protein or enzyme. ( CSP )] (UMLS (CSP) C0025534) =Disease or Syndrome =Congenital Metabolic Disorder;
metal metabolism disorder =cerebral pseudosclerosis;
kinky hair syndrome;
familial periodic paralysis;
hereditary hemochromatosis;
diabetes bronze;
cerebral pseudosclerosis;
hypophosphatasia;
Hypophosphatemia, Familial;
kinky hair syndrome;
familial periodic paralysis;
Albright's hereditary osteodystrophy;
|
- 24. In process, scheduled
- (UMLS (HL7) C1546447) =Idea or Concept =Order status;
| - 74. inborn renal tubular transport disorder
- [genetically determined disorders of the reabsorptive functions of the kidney with regard to specific nephron segments responsible for specific transport functions, classifiable by proximal nephron function, loop of Henle function, and distal nephron function; transport defects can be selective or nonselective. ( CSP )] (UMLS (CSP) C0035091) =Disease or Syndrome =Kidney Disease;
Congenital Metabolic Disorder;
inborn biological transport disorder;
=Acidosis, Renal Tubular;
Aminoaciduria, Renal;
cystine storage disease;
cystinuria;
cerebrooculorenal syndrome;
Acidosis, Renal Tubular;
Aminoaciduria, Renal;
cystine storage disease;
DIABETES RENALA;
Hypophosphatemia, Familial;
cerebrooculorenal syndrome;
Pseudohypoaldosteronism;
|
- 25. In process, unspecified
- (UMLS (HL7) C1546445) =Idea or Concept =Order status;
| - 75. inborn reticuloendothelial disorder
- [ ] (UMLS (CSP) C0598677) =Disease or Syndrome ;
|
- 26. In Progress
- [A workflow status where the material has been assigned to personnel to perform the task of transcription. The document remains in this state until the document is transcribed. ( HL7V3.0 )] (UMLS (HL7) C1548387) =Idea or Concept =Document completion status;
DocumentCompletion | - 76. inborn urea cycle disorder
- [inherited errors in the metabolic reactions occurring in the liver that convert ammonia to urea, resulting from inborn genetic mutations. ( CSP )] (UMLS (CSP) C0596767) =Disease or Syndrome =Amino Acid Metabolism, Inborn Errors;
=arginosuccinate synthetase deficiency;
arginase deficiency;
arginosuccinate lyase deficiency;
OCP deficiency;
CAPS deficiency;
|
- 27. In Situ
- [in the natural or normal place, confined to the site of origin without invasion of neighboring tissues. ( NCI )] (UMLS (NCI) C0444498) =Spatial Concept
| - 77. inbreeding
- [the crossing of closely related plants or animals. ( CSP )] (UMLS (CSP) C0021144) =Organism Function ;
=Genetics, Population;
|
- 28. In Situ Lesion
- (UMLS (NCI) C1334167) =Finding ;
| - 78. INC SOFT TISSUE HAND NEC
- [ ] (UMLS (ICD9CM) C0177580) =Therapeutic or Preventive Procedure
|
- 29. in situ nick end labeling
- [an in situ method for detecting areas of DNA which are nicked during apoptosis; terminal deoxynucleotidyl transferase is used to add labeled dUTP, in a template-independent manner, to the 3 primer OH ends of either single- or double-stranded DNA; assay labels apoptosis on a single-cell level, making it more sensitive than agarose gel electrophoresis for analysis of DNA fragmentation. ( CSP )] (UMLS (CSP) C0600528) =Molecular Biology Research Technique ;
=genetic technique;
| - 79. INC/EXC/DESTR IN EAR NEC
- (UMLS (ICD9CM) C0176346) =Therapeutic or Preventive Procedure
|
- 30. in the evening at institution-specified time
- (UMLS (HL7) C1548626) =Temporal Concept =Repeat;
| - 80. incapable
- [Target person is not capable of comprehending the issue. ( HL7V3.0 )] (UMLS (HL7) C1550518) =Idea or Concept =TargetAwareness;
|
- 31. in the morning at institution-specified time
- (UMLS (HL7) C1548623) =Temporal Concept =Repeat;
| - 81. Incapacity which is significant, persistent or permanent
- (UMLS (HL7) C1546951) =Idea or Concept =Event Consequence;
|
- 32. in utero diagnosis
- [ ] (UMLS (CSP) C0599189) =Diagnostic Procedure ;
| - 82. incarceration
- [ ] (UMLS (CSP) C0205255) =Governmental or Regulatory Activity
|
- 33. in utero transplantation
- [therapeutic transplantation of cells or tissue into the fetus while in the uterus. ( CSP )] (UMLS (CSP) C0872317) intrauterine transplantation;
prenatal transplantation =Therapeutic or Preventive Procedure ;
=transplantation;
embryo/fetus surgery | - 83. Incel
- (UMLS (NCI) C1259141) =Organic Chemical; Pharmacologic Substance ;
|
- 34. in vitro Fertilization
- [a process whereby (usually multiple) ova are placed in a medium to which sperm are added for fertilization, the zygote thus produced is then introduced in the uterus. ( CSP )] (UMLS (NCI) C0015915) =Therapeutic or Preventive Procedure ;
=Fertility/Fertilization;
assistive reproductive technique | - 84. Incentive
- [A benefit, consideration, or positive motivational influence, financial or otherwise, given to induce a specific action. ( NCI )] (UMLS (NCI) C0021147) =Qualitative Concept ;
|
- 35. in vitro Sensitivity-Directed Chemotherapy
- [Uses the results of a chemosensitivity testing assay to tailor the treatment to the individual. ( NCI )] (UMLS (NCI) C0281488) =Therapeutic or Preventive Procedure
| - 85. incest
- [Sexual intercourse between persons so closely related that they are forbidden by law to marry. ( MSH )] (UMLS (CSP) C0021148) =Mental or Behavioral Dysfunction ;
|
- 36. in vitro-treated PBPC transplantation
- (UMLS (NCI) C0280914) =Therapeutic or Preventive Procedure
| - 86. inch of mercury column
- [1 m[Hg].[in_i]/m ( HL7V3.0 )] (UMLS (HL7) C1552981) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 37. In Vivo & In Vitro Nuclear Medicine
- (UMLS (HL7) C1555784) =Intellectual Product =Nuclear Medicine;
| - 87. inch of water column
- [1 m[H2O].[in_i]/m ( HL7V3.0 )] (UMLS (HL7) C1552980) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 38. In113M isotope
- [ ] (UMLS (CSP) C0303404) =Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope ;
| - 88. incidence
- [The number of new cases of a disease diagnosed each year. ( NCI )] (UMLS (NCI) C0021149) =Quantitative Concept ;
|
- 39. Inactivated Vaccine
- [A preparation of killed microorganisms that is intended to prevent or treat an infectious disease by inducing active immunity to the causative microorganism. (NCI04) ( NCI )] (UMLS (NCI) C0042212) =Pharmacologic Substance; Immunologic Factor ;
| - 89. incident
- [An event that occurred outside of the control of one or more of the parties involved. Includes the concept of an accident. ( HL7V3.0 )] (UMLS (HL7) C1551358) =Idea or Concept =act;
|
- 40. Inactive
- (UMLS (HL7) C1547420) =Idea or Concept =Certificate Status;
| - 90. Incident Type Code
- (UMLS (HL7) C1547809) =Intellectual Product =HL7 Vocabulary Version 2.5;
=Other;
Preventable;
User Error;
|
- 41. Inactive
- (UMLS (HL7) C1608264) =Idea or Concept =Immunization Registry Status;
| - 91. Incidental appendectomy
- [Surgical removal of the vermiform appendix, performed incidentally to another primary surgical procedure. ( NCI )] (UMLS (ICD9CM) C0192882) =Therapeutic or Preventive Procedure
|
- 42. Inactive
- [A previously active item has been retired from use. The item may exist as previously stored data in a database, but no current or new HL7 standards or messges should use this item. The code for an inactive item will not be reused by HL7. ( HL7V3.0 )] (UMLS (HL7) C1608263) =Idea or Concept ;
=EditStatus;
| - 92. Incidental Finding
- [An asymptomatic benign or malignant lesion discovered during an endoscopic, surgical, or radiologic procedure performed for unrelated reasons. ( NCI )] (UMLS (NCI) C0743997) =Finding
|
- 43. Inactive - Lost to follow-up (cancel contract)
- (UMLS (HL7) C1547421) =Idea or Concept =Immunization Registry Status;
| - 93. incidental service delivery location
- [A role played by a place at which health care services may be provided without prior designation or authorization. ( HL7V3.0 )] (UMLS (HL7) C1555343) =Spatial Concept =service delivery location;
|
- 44. Inactive - Moved or gone elsewhere (cancel contract)
- (UMLS (HL7) C1547422) =Idea or Concept =Immunization Registry Status;
| - 94. IncidentalServiceDeliveryLocationRoleType
- (UMLS (HL7) C1698904) =Intellectual Product =ServiceDeliveryLocationRoleType;
=Community Location;
Patient's Residence;
accident site;
work site;
school;
|
- 45. Inactive - Permanently inactive (Do not reactivate or add new entries to the record)
- (UMLS (HL7) C1547423) =Idea or Concept =Immunization Registry Status;
| - 95. INCIPIENT CATARACT
- (UMLS (ICD9CM) C0271163) =Acquired Abnormality; Disease or Syndrome
|
- 46. inactive ingredient
- (UMLS (HL7) C1552019) =Chemical Viewed Functionally =ingredient;
=Drug Preservative;
flavor;
stabilizer;
color | - 96. INCIS CX TO ASSIST DELIV
- [ ] (UMLS (ICD9CM) C0195612) =Therapeutic or Preventive Procedure
|
- 47. INACTIVE MENIERE'S DIS
- (UMLS (ICD9CM) C0155499) =Disease or Syndrome ;
| - 97. INCIS HERN REP-GRFT/PROS
- [ ] (UMLS (ICD9CM) C0405657) =Therapeutic or Preventive Procedure
|
- 48. Inactive Pancreatic Endocrine Neoplasm
- [A usually malignant pancreatic endocrine neoplasm which may be associated with elevated hormonal levels in the blood or show positive tissue immunologic reaction to hormonal antibodies, but it is not associated with a hormonal syndrome. ( NCI )] (UMLS (NCI) C1334977) Inactive Pancreatic Endocrine Tumor;
Non-Functioning Pancreatic Endocrine Neoplasm;
Non-Functioning Pancreatic Endocrine Tumor;
Nonsyndromic Pancreatic Endocrine Neoplasm;
Nonsyndromic Pancreatic Endocrine Tumor =Neoplastic Process | - 98. INCIS LARYNX TRACHEA NEC
- [ ] (UMLS (ICD9CM) C0176476) =Therapeutic or Preventive Procedure
|
- 49. Inactive Reason Code
- (UMLS (HL7) C1547911) =Intellectual Product =HL7 Vocabulary Version 2.5;
=Leave of Absence;
Retired;
Termination | - 99. INCIS LYMPHATIC STRUCTUR
- [ ] (UMLS (ICD9CM) C0176696) =Therapeutic or Preventive Procedure
|
- 50. Inactive Staff
- (UMLS (HL7) C1549614) =Idea or Concept =Active/Inactive;
| - 100. INCIS OBSTR BILE DUC NEC
- [ ] (UMLS (ICD9CM) C0176909) =Therapeutic or Preventive Procedure
|
home
